NFkB ELISA Kits

NFKB ELISA Kits

NFκB (Nuclear Factor kappa-light-chain-enhancer of activated B cells) ELISA kits are immunoassays designed to measure the levels or activity of NFκB in various biological samples such as cell lysates and tissue extracts. NFκB is a transcription factor that plays a crucial role in regulating the immune response, inflammation, cell proliferation, and apoptosis. Dysregulation of NFκB signaling is linked to numerous diseases, including cancer, autoimmune disorders, and chronic inflammation, making NFκB ELISA kits valuable for both research and clinical applications.

Content of NFκB ELISA Kits: NFκB ELISA kits typically include:

• A 96-well microplate pre-coated with capture antibodies specific to NFκB subunits (e.g., p65).
• Recombinant NFκB protein standards for generating a standard curve.
• Detection antibodies, often conjugated to an enzyme such as HRP (Horseradish Peroxidase).
• Substrate solution (e.g., TMB – 3,3',5,5'-Tetramethylbenzidine) for colorimetric detection.
• Stop solution to terminate the reaction.
• Assay and sample diluents, wash buffers, and a detailed instruction manual for performing the assay.

Application of NFκB ELISA Kits: NFκB ELISA kits are used in a variety of research and clinical settings, including:

• Inflammatory research: Quantifying NFκB activity to study its involvement in inflammatory pathways and cytokine regulation in conditions like rheumatoid arthritis, inflammatory bowel disease (IBD), and asthma.
• Cancer research: Investigating the role of NFκB in tumorigenesis, as its activation is associated with cell proliferation, angiogenesis, and resistance to apoptosis in several types of cancer.
• Immunology: Assessing NFκB as a key regulator of immune responses, particularly in the context of pathogen detection, immune cell activation, and adaptive immunity.
• Neuroscience: Exploring NFκB's role in neuroinflammatory processes related to neurodegenerative diseases such as Alzheimer’s and Parkinson’s.
• Drug development and screening: Evaluating the effects of potential inhibitors or modulators of NFκB pathways in preclinical and clinical trials to develop anti-inflammatory and anticancer therapies.

NFκB ELISA kits provide reliable and sensitive quantification, essential for studying the molecular mechanisms underlying immune and inflammatory responses and their implications in health and disease.